翻訳と辞書 Words near each other ・ Abby & Brittany ・ Abby (Doctor Who) ・ Abbott Government ・ Abbott Graves House ・ Abbott Hall Brisbane ・ Abbott Handerson Thayer ・ Abbott High School ・ Abbott Hospital ・ Abbott House ・ Abbott House (childcare agency) ・ Abbott House, California ・ Abbott Independent School District ・ Abbott Island ・ Abbott Island (Wessel Islands) ・ Abbott Laboratories ・ Abbott Laboratories v. Gardner ・ Abbott Lawrence ・ Abbott Lawrence Lowell ・ Abbott Lawrence Pattison ・ Abbott Lawrence Rotch ・ Abbott Lowell Cummings ・ Abbott Mead Vickers BBDO ・ Abbott Memorial Alumni Stadium ・ Abbott Memorial Library ・ Abbott Ministry ・ Abbott Mysteries ・ Abbott Northwestern Hospital ・ Abbott Papyrus ・ Abbott Payson Usher ・ Abbott Peak (Antarctica) Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Abbott Laboratories v. Gardner ： ウィキペディア英語版 Abbott Laboratories v. Gardner ''Abbott Laboratories v. Gardner'', , was a case heard before the United States Supreme Court. Abbott Laboratories held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials. The government argued that the case was not ripe because the regulation had yet to be enforced; however, that argument failed as the Court found the issues to be fit for judicial resolution, and that the drug companies would experience substantial hardship if denied a pre-enforcement challenge to the statute. Prosecution for non-compliance was likely, civil and criminal penalties could be imposed, and the drug companies would suffer reputational damage if required to violate the regulation before challenging it in court. == Facts == The action was brought by individuals and associations accounting for more than 90% of the prescription drugs industry. Specifically, the petitioners challenged the decision by the Commissioner of Food and Drug to promulgate the "established name" rule pursuant to a statute granted by Congress. After inviting and considering comments submitted by interested parties, the Commissioner established the following rule: :''If the label or labeling of a prescription drug bears a proprietary name or designation for the drug or any ingredient thereof, the established name, if such there be, corresponding, to such proprietary name or designation, shall accompany each appearance of such proprietary name or designation.'' 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Abbott Laboratories v. Gardner」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.